Rheumatology APCM Care Plan Creation: A Step-by-Step Guide
Optimize APCM care plan creation for rheumatology practices. Improve biologic monitoring and RA flare management with AI-driven workflows.
Effective Principal Care Management (APCM) in rheumatology requires a structured approach to managing complex autoimmune conditions like RA, Lupus, and Psoriatic Arthritis. This guide outlines a streamlined workflow for creating comprehensive care plans that address biologic therapy, flare management, and the high comorbidity rates inherent in chronic inflammatory diseases.
Rheumatology practices face 3-6 month wait times and high administrative burdens from biologic REMS programs and lab monitoring. Manual care plan creation often leads to gaps in immunosuppression oversight and missed revenue opportunities in APCM billing.
Step-by-Step Workflow
Patient Identification & Risk Stratification
Identify high-risk autoimmune patients requiring biologic therapy or those with frequent flares using AI-filtered EHR data to prioritize APCM enrollment.
- Target patients on JAK inhibitors or TNF blockers first
- Filter by ICD-10 codes for RA, SLE, and PsA
- Waiting for the patient to request care management
- Ignoring stable patients who still require intensive lab monitoring
Initial Assessment & Lab Baseline
Conduct a comprehensive review of current immunosuppression, baseline inflammatory markers such as CRP/ESR, and specific organ involvement for lupus patients.
- Include recent TB and Hepatitis screening results
- Document baseline joint counts (SJC/TJC)
- Failing to document the specific 'high-risk' nature of the condition
- Incomplete medication reconciliation of specialty drugs
Biologic Monitoring Schedule Integration
Map out specific lab intervals required for biologic REMS compliance and safety monitoring, including LFTs, CBC, and renal function tests.
- Align lab orders with APCM monthly check-in cycles
- Automate reminders for q3-month monitoring
- Missing quarterly safety labs for patients on methotrexate
- Inconsistent tracking of infusion therapy dates
Flare Management Protocol Design
Establish clear patient-facing instructions for identifying and reporting flares between scheduled monthly visits to prevent ER utilization.
- Define specific 'red flag' symptoms for systemic involvement
- Provide a clear pathway for prednisone bridge therapy if needed
- Vague instructions that lead to unnecessary urgent care visits
- Lack of a dedicated phone triage line for flare reporting
Comorbidity & Mental Health Screening
Incorporate screenings for common rheumatologic comorbidities like cardiovascular disease, osteoporosis, and depression into the care plan.
- Use PHQ-9 for routine depression screening
- Track DEXA scan intervals for patients on long-term steroids
- Focusing solely on joint pain while ignoring systemic risks
- Failing to coordinate with the patient's primary care physician
APCM Documentation & Consent
Formalize the electronic care plan within the EHR, ensuring patient verbal or written consent is recorded for monthly 20-minute APCM billing.
- Use a standardized APCM template for consistency
- Ensure the care plan is shared with the patient via portal
- Missing the 20-minute threshold for billable time
- Inadequate documentation of 'non-face-to-face' coordination
AI-Powered Follow-up Automation
Deploy automated call systems to schedule routine lab work and monthly check-ins, ensuring the care plan remains active and compliant without manual staff effort.
- Use AI to capture patient-reported outcome measures (PROMs)
- Trigger alerts for patients who miss monitoring appointments
- Relying on manual calling for hundreds of APCM patients
- Ignoring patient preferences for communication channels
Expected Outcomes
Increased adherence to biologic monitoring protocols
Reduced emergency visits for unmanaged autoimmune flares
Improved APCM billing capture and practice revenue
Enhanced patient engagement between quarterly visits
Better documentation for ACR treatment guideline compliance
Frequently Asked Questions
APCM (Principal Care Management) focuses on a single high-risk condition managed by a specialist, whereas CCM requires two or more chronic conditions. APCM is ideal for rheumatologists managing complex biologic therapies for a single primary diagnosis like RA.
You must document at least 20 minutes of non-face-to-face care per month, including a transition of care, medication reconciliation, and a comprehensive care plan that is accessible to the patient 24/7.
While AI doesn't sign the PA, it can automate the collection of necessary clinical data from patients, track renewal dates, and notify patients when approvals are received, significantly reducing staff phone time.
Yes, patients receiving infusions like infliximab or rituximab are excellent candidates for APCM, as they require intensive monitoring, pre-medication coordination, and post-infusion follow-up.
Ready to transform your rheumatology practice?
See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.
Schedule a Demo